Certificate of Analysis

370 in stock

Quantity Price / Per Vial
1 – 3 $100.00
4 – 7 $90.00
8+ $80.00

GLP1-SMA 5MG

$100.00

GLP1-SMA: Research GLP-1 Receptor Agonist (Incretin Pathway) 1× GLP1-SMA (5mg)

Key Features
  • High-purity GLP-1 receptor research peptide
  • Lyophilized for stability and accurate laboratory handling
  • QC verified for identity and batch consistency

Description

GLP1-SMA

GLP1-SMA — Research Peptide (GLP-1 Receptor Agonist)

GLP1-SMA is a research-use-only peptide analog designed to interact with the glucagon-like peptide-1 (GLP-1) receptor pathway. It is supplied exclusively for non-clinical laboratory research focused on incretin signaling and metabolic pathway investigation.

Research Focus (Non-Clinical):

  • Pancreatic signaling models involving glucose-dependent insulin and glucagon regulation
  • Gastrointestinal pathway research related to gastric emptying and post-prandial glucose dynamics
  • Central GLP-1 receptor signaling associated with appetite and satiety mechanisms
  • Exploratory cardiometabolic research panels evaluating lipid markers and related physiological proxies

Notes for Investigators:

This compound is intended for controlled laboratory research exploring GLP-1 receptor activity and related metabolic signaling pathways, including use in multi-pathway or combination research models.

Regulatory & Use:

  • For laboratory research use only
  • Not a drug, food, cosmetic, or medical device
  • Not for human or veterinary use
  • No therapeutic, diagnostic, or dosing claims are made
Description

Description

GLP1-SMA

GLP1-SMA — Research Peptide (GLP-1 Receptor Agonist)

GLP1-SMA is a research-use-only peptide analog designed to interact with the glucagon-like peptide-1 (GLP-1) receptor pathway. It is supplied exclusively for non-clinical laboratory research focused on incretin signaling and metabolic pathway investigation.

Research Focus (Non-Clinical):

  • Pancreatic signaling models involving glucose-dependent insulin and glucagon regulation
  • Gastrointestinal pathway research related to gastric emptying and post-prandial glucose dynamics
  • Central GLP-1 receptor signaling associated with appetite and satiety mechanisms
  • Exploratory cardiometabolic research panels evaluating lipid markers and related physiological proxies

Notes for Investigators:

This compound is intended for controlled laboratory research exploring GLP-1 receptor activity and related metabolic signaling pathways, including use in multi-pathway or combination research models.

Regulatory & Use:

  • For laboratory research use only
  • Not a drug, food, cosmetic, or medical device
  • Not for human or veterinary use
  • No therapeutic, diagnostic, or dosing claims are made

Related products